Cargando…

MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression

Breast cancer manifests as a spectrum of subtypes with distinct molecular signatures, and different responses to treatment. Of these subtypes, triple-negative breast cancer (TNBC) has the worst prognoses and limited therapeutic options. Here we report aberrant expression of microRNA-138 (miR-138) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nama, Srikanth, Muhuri, Manish, Di Pascale, Federica, Quah, Shan, Aswad, Luay, Fullwood, Melissa, Sampath, Prabha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722084/ https://www.ncbi.nlm.nih.gov/pubmed/31481748 http://dx.doi.org/10.1038/s41598-019-49155-4

Ejemplares similares

C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
por: Di Pascale, Federica, et al.
Publicado: (2018)

The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs
por: Rutnam, Zina Jeyapalan, et al.
Publicado: (2014)

HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis
por: Yan, TingDong, et al.
Publicado: (2018)

The Biological Function of TUSC7/miR-1224-3p Axis in Triple-Negative Breast Cancer
por: Zheng, Bo-Hao, et al.
Publicado: (2021)

EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis
por: Sundaram, Gopinath M., et al.
Publicado: (2017)

TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis
por: Liu, Fengqiong, et al.
Publicado: (2018)

MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2
por: Xie, Hui Hui, et al.
Publicado: (2019)

Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)

LncRNA CCAT1 Promotes Colorectal Cancer Tumorigenesis Via A miR-181b-5p/TUSC3 Axis
por: Chen, Si, et al.
Publicado: (2019)

Downregulation of microRNA-320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3
por: Kong, Li, et al.
Publicado: (2020)

Metastasis suppression and enhancement of anti-tumour immunity by targeting the FSTL1-DIP2A axis
por: Sundaram, Gopinath M., et al.
Publicado: (2019)

Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis
por: Fan, Xiaoqiang, et al.
Publicado: (2016)

FORALL: an interactive shiny/R web portal to navigate multi-omics high-throughput data of pediatric acute lymphoblastic leukemia
por: Aswad, Luay, et al.
Publicado: (2023)

Long-Distance Repression by Human Silencers: Chromatin Interactions and Phase Separation in Silencers
por: Zhang, Ying, et al.
Publicado: (2022)

Correction: Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis
Publicado: (2016)

TUSC3: a novel tumour suppressor gene and its functional implications
por: Yu, Xinshuang, et al.
Publicado: (2017)

Two Sisters From Qatar With TUSC3 Genetic Mutation: Psychiatric Considerations
por: Albobali, Yahia, et al.
Publicado: (2021)

Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy
por: Arrigo, Austin, et al.
Publicado: (2023)

microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis
por: Zhang, Cen, et al.
Publicado: (2016)

MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway
por: Wei, Xiaoyong, et al.
Publicado: (2019)

MicroRNA-138 is a potential regulator of memory performance in humans
por: Schröder, Julia, et al.
Publicado: (2014)

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2019)

Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects
por: Ivanova, Alla V, et al.
Publicado: (2009)

TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
por: Yan, Youji, et al.
Publicado: (2019)

TUSC3 Methylation in Peripheral Blood Cells as a Biomarker for Diagnosis of Colorectal Cancer
por: Siri, Goli, et al.
Publicado: (2023)

Paragraph 138
por: Lippe, Ad.
Publicado: (1887)

MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer
por: Zhang, Li, et al.
Publicado: (2019)

Egr2-dependent microRNA-138 is dispensable for peripheral nerve myelination
por: Lin, Hsin-Pin, et al.
Publicado: (2018)

MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin
por: Yoo, Ji-Young, et al.
Publicado: (2021)

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
por: Yeh, Margaret, et al.
Publicado: (2021)

Genome-wide haploinsufficiency screen reveals a novel role for γ-TuSC in spindle organization and genome stability
por: Choy, John S., et al.
Publicado: (2013)

Microtubule nucleating γTuSC assembles structures with 13-fold microtubule-like symmetry
por: Kollman, Justin M., et al.
Publicado: (2010)

TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo
por: Horak, Peter, et al.
Publicado: (2014)

The microtubule polymerase Stu2 promotes oligomerization of the γ-TuSC for cytoplasmic microtubule nucleation
por: Gunzelmann, Judith, et al.
Publicado: (2018)

Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211
por: Cong, Menglin, et al.
Publicado: (2019)

LncRNA TUSC8 suppresses the proliferation and migration of esophageal cancer cells by downregulation of VEGFA
por: Hu, Rui, et al.
Publicado: (2021)

Over-Expression of Two Different Isoforms of Cattle TUSC5 Showed Opposite Effects on Adipogenesis
por: Xia, Han, et al.
Publicado: (2022)

Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis
por: Deng, Ruxia, et al.
Publicado: (2022)

Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
por: Wu, Qiong, et al.
Publicado: (2023)

EBV reactivation as a target of luteolin to repress NPC tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_322fe6opikhql2i5n6gmemu601